To further improve their prognosis and quality of life, we adopted iTRAQ-based quantitative proteomics technology to screen the differentially expressed proteins (DEPs) between ER + breast cancer and corresponding adjacent normal tissue. Here, ESR1 is linked to breast carcinoma.